Hunterian Medicine

DI

Diabetes Prevention Program10 shared keywords

AS

Ascidian Therapeutics7 shared keywordsAscidian Therapeutics develops RNA exon editing technology that rewrites RNA by editing and replacing human exons, aiming to create a class of medicines addressing the underlying genetic causes of disease. Its platform targets diseases not addressed by DNA-based gene editing, offering post-transcriptional editing that produces full-length functional proteins.

RE

ResearchGate6 shared keywords

TH

Thumbnail for Lyterian Therapeutics4 shared keywords

DE

Dervan et al4 shared keywords

ST

Statnews4 shared keywords

TE

Telperian3 shared keywords

CO

Conor Walsh3 shared keywordsHarvard University is a higher-education and research institution whose schools and faculty conduct medical and scientific research across areas such as chronic disease, public health, and engineering. The page highlights research on conditions including cardiovascular disease, chronic pain, lung disease, and tissue engineering.

VI

Viridian Therapeutics3 shared keywordsViridian Therapeutics develops treatments for thyroid eye disease, a rare autoimmune condition affecting the eyes and orbit. The company focuses on clinical development and patient support programs in the biotech sector.

AR

ARISAN THERAPEUTICS INC3 shared keywords

Companies competing with Hunterian Medicine for the same Google search keywords, organic and paid, via search-intersection analysis.

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.